+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefaclor"

Cefaclor Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cefaclor Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
From
Cephalosporin Drugs Market Report 2025 - Product Thumbnail Image

Cephalosporin Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2024
  • 135 Pages
  • China
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Cefaclor is a cephalosporin antibiotic used to treat a variety of respiratory infections, including bronchitis, pneumonia, and sinusitis. It is also used to treat ear, throat, and urinary tract infections. Cefaclor is available in both oral and intravenous forms. It is generally well tolerated, with few side effects. Cefaclor is a popular choice for treating respiratory infections due to its broad spectrum of activity and low cost. It is often prescribed as a first-line treatment for mild to moderate infections. It is also used in combination with other antibiotics to treat more severe infections. The cefaclor market is highly competitive, with many generic and branded products available. Major players in the market include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Other companies include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more